What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Cancer
His primary scientific interests are in Semaphorin, Immunology, Cell biology, Immune system and SEMA4D.
His Semaphorin research integrates issues from Axon guidance and Neuroscience.
His Cell biology research incorporates themes from Cellular differentiation, CD40, T cell, Antigen-presenting cell and Dendritic cell.
The concepts of his Immune system study are interwoven with issues in Cytokine, Antigen and Lactic acid.
His SEMA4D research is multidisciplinary, relying on both CD72, Cellular immunity, Stereochemistry, Sema domain and Oligodendrocyte.
He has included themes like Cytoplasm, Signal transduction, Function and Phosphorylation in his Receptor study.
His most cited work include:
- Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders (569 citations)
- Osteoprotection by semaphorin 3A (337 citations)
- Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. (315 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Immunology, Semaphorin, Immune system, Internal medicine and Cell biology.
His Pathogenesis, Rheumatoid arthritis, Inflammation, Antibody and Autoantibody study are his primary interests in Immunology.
The various areas that Atsushi Kumanogoh examines in his Semaphorin study include Axon guidance and Neuroscience.
While the research belongs to areas of Immune system, he spends his time largely on the problem of Cancer research, intersecting his research to questions surrounding Cancer immunotherapy.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Oncology.
The Cell biology study combines topics in areas such as Cytotoxic T cell and Biochemistry.
He most often published in these fields:
- Immunology (31.49%)
- Semaphorin (23.68%)
- Immune system (21.66%)
What were the highlights of his more recent work (between 2019-2021)?
- Internal medicine (20.65%)
- Cancer research (17.63%)
- Immune system (21.66%)
In recent papers he was focusing on the following fields of study:
Atsushi Kumanogoh mostly deals with Internal medicine, Cancer research, Immune system, Immunology and Antibody.
The study incorporates disciplines such as Gastroenterology and Cardiology in addition to Internal medicine.
His Immune system research incorporates elements of Inflammation, Hypoxia, Pulmonary hypertension and Fibrosis.
His studies link Host with Immunology.
As part of one scientific family, Atsushi Kumanogoh deals mainly with the area of Antibody, narrowing it down to issues related to the Immunotherapy, and often Cell, Cytotoxic T cell, T cell, Glucose test and Monoclonal.
Cell biology is closely connected to Lymphangioleiomyomatosis in his research, which is encompassed under the umbrella topic of Extracellular vesicles.
Between 2019 and 2021, his most popular works were:
- Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population (36 citations)
- LRRK2 regulates endoplasmic reticulum-mitochondrial tethering through the PERK-mediated ubiquitination pathway. (17 citations)
- Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells. (6 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Cancer
His primary areas of investigation include Immune system, Immunology, Cancer research, Antibody and Immunotherapy.
Atsushi Kumanogoh has researched Immune system in several fields, including Hypoxia, Pulmonary hypertension and Pathogenesis.
His Immunology study incorporates themes from Host and SEMA4D.
His research in Cancer research intersects with topics in Cell, CD8, Cancer immunotherapy, Thymic carcinoma and Cytotoxic T cell.
His studies deal with areas such as Strictly standardized mean difference, Nasal Lavage Fluid, Thymoma, Therapeutic effect and Subgroup analysis as well as Antibody.
His work deals with themes such as Vasculitis, Flow cytometry, Cytokine and Cytotoxicity, which intersect with Immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
